• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合配体预测的腺苷受体 3D 结构:与晶体结构的比较。

Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.

机构信息

Materials and Process Simulation Center (MC139-74), California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125, USA.

出版信息

J Struct Biol. 2010 Apr;170(1):10-20. doi: 10.1016/j.jsb.2010.01.001. Epub 2010 Jan 15.

DOI:10.1016/j.jsb.2010.01.001
PMID:20079848
Abstract

G protein-coupled receptors (GPCRs) are therapeutic targets for many diseases, but progress in developing active and selective therapeutics has been severely hampered by the difficulty in obtaining accurate structures. We have been developing methods for predicting the structures for GPCR ligand complexes, but validation has been hampered by a lack of experimental structures with which to compare our predictions. We report here the predicted structures of the human adenosine GPCR subtypes (A(1), A(2A), A(2B), and A(3)) and the binding sites for adenosine agonist and eight antagonists to this predicted structure, making no use of structural data, and compare with recent experimental crystal structure for ZM241385 bound human A(2A) receptor. The predicted structure correctly identifies 9 of the 12 crystal binding site residues. Moreover, the predicted binding energies of eight antagonists to the predicted structure of A(2A) correlate quite well with experiment. These excellent predictions resulted when we used Monte Carlo techniques to optimize the loop structures, particularly the cysteine linkages. Ignoring these linkages led to a much worse predicted binding site (identifying only 3 of the 12 important residues). These results indicate that computational methods can predict the three-dimensional structure of GPCR membrane proteins sufficiently accurately for use in designing subtype selective ligands for important GPCR therapeutics targets.

摘要

G 蛋白偶联受体 (GPCR) 是许多疾病的治疗靶点,但由于难以获得准确的结构,开发活性和选择性治疗药物的进展受到了严重阻碍。我们一直在开发预测 GPCR 配体复合物结构的方法,但由于缺乏可用于比较我们预测结果的实验结构,验证受到了阻碍。我们在此报告了人类腺苷 GPCR 亚型 (A(1)、A(2A)、A(2B) 和 A(3)) 的预测结构,以及与该预测结构结合的腺苷激动剂和 8 种拮抗剂的结合位点,不使用结构数据,并与最近报道的 ZM241385 结合人 A(2A) 受体的实验晶体结构进行比较。预测结构正确识别了 12 个晶体结合位点残基中的 9 个。此外,预测的 8 种拮抗剂与 A(2A) 预测结构的结合能与实验结果相当吻合。当我们使用蒙特卡罗技术优化环结构,特别是半胱氨酸键时,产生了这些出色的预测结果。忽略这些键会导致预测的结合位点变差(仅识别 12 个重要残基中的 3 个)。这些结果表明,计算方法可以足够准确地预测 GPCR 膜蛋白的三维结构,可用于设计针对重要 GPCR 治疗靶点的亚型选择性配体。

相似文献

1
Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.结合配体预测的腺苷受体 3D 结构:与晶体结构的比较。
J Struct Biol. 2010 Apr;170(1):10-20. doi: 10.1016/j.jsb.2010.01.001. Epub 2010 Jan 15.
2
Beyond rhodopsin: G protein-coupled receptor structure and modeling incorporating the beta2-adrenergic and adenosine A(2A) crystal structures.超越视紫红质:结合β2肾上腺素能受体和腺苷A(2A)晶体结构的G蛋白偶联受体结构与建模
Methods Mol Biol. 2011;672:359-86. doi: 10.1007/978-1-60761-839-3_15.
3
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.线性和非线性3D-QSAR方法与基于配体的同源性建模相结合,作为一种计算策略来描绘人腺苷A2A受体的吡唑并三唑并嘧啶拮抗剂结合位点。
J Chem Inf Model. 2008 Feb;48(2):350-63. doi: 10.1021/ci700300w. Epub 2008 Jan 24.
4
Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.激动剂诱导的牛视紫红质构象变化:深入了解G蛋白偶联受体的激活
J Mol Biol. 2008 Oct 3;382(2):539-55. doi: 10.1016/j.jmb.2008.06.084. Epub 2008 Jul 7.
5
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.激动剂结合的腺苷 A2A 受体结构揭示了 G 蛋白偶联受体激活的共同特征。
Nature. 2011 May 18;474(7352):521-5. doi: 10.1038/nature10136.
6
Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.肾上腺素能受体中配体结合及特异性的结构基础:对G蛋白偶联受体靶向药物发现的启示
Biochemistry. 2008 Oct 21;47(42):11013-23. doi: 10.1021/bi800891r. Epub 2008 Sep 27.
7
Molecular dynamics simulations reveal insights into key structural elements of adenosine receptors.分子动力学模拟揭示了对腺苷受体关键结构元素的深入了解。
Biochemistry. 2011 May 17;50(19):4194-208. doi: 10.1021/bi200100t. Epub 2011 Apr 20.
8
PREDICT modeling and in-silico screening for G-protein coupled receptors.针对G蛋白偶联受体的PREDICT建模与计算机模拟筛选
Proteins. 2004 Oct 1;57(1):51-86. doi: 10.1002/prot.20195.
9
Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors.基于结构的G蛋白偶联受体结合位点、天然配体及潜在抑制剂的鉴定
Proteins. 2003 May 15;51(3):423-33. doi: 10.1002/prot.10362.
10
The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design.人源腺苷 A2A 受体在高亲和力拮抗剂结合状态下的晶体结构:对 GPCR 药物筛选和设计的启示。
Curr Opin Struct Biol. 2010 Aug;20(4):401-14. doi: 10.1016/j.sbi.2010.05.002. Epub 2010 Jun 9.

引用本文的文献

1
Methotrexate Inhibits the Binding of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Receptor Binding Domain to the Host-Cell Angiotensin-Converting Enzyme-2 (ACE-2) Receptor.甲氨蝶呤抑制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体结合域与宿主细胞血管紧张素转换酶2(ACE-2)受体的结合。
ACS Pharmacol Transl Sci. 2024 Jan 16;7(2):348-362. doi: 10.1021/acsptsci.3c00197. eCollection 2024 Feb 9.
2
Predicted structure of fully activated human bitter taste receptor TAS2R4 complexed with G protein and agonists.与G蛋白和激动剂复合的完全激活的人类苦味受体TAS2R4的预测结构。
QRB Discov. 2021 Apr 8;2:e3. doi: 10.1017/qrd.2021.1. eCollection 2021.
3
The ÓMICAS alliance, an international research program on multi-omics for crop breeding optimization.
ÓMICAS联盟,一个旨在优化作物育种的多组学国际研究项目。
Front Plant Sci. 2022 Oct 10;13:992663. doi: 10.3389/fpls.2022.992663. eCollection 2022.
4
Biased β-Agonists Favoring Gs over β-Arrestin for Individualized Treatment of Obstructive Lung Disease.偏向性β激动剂在阻塞性肺病个体化治疗中对Gs的偏好超过β抑制蛋白
J Pers Med. 2022 Feb 22;12(3):331. doi: 10.3390/jpm12030331.
5
Identification and characterization of an atypical Gαs-biased βAR agonist that fails to evoke airway smooth muscle cell tachyphylaxis.鉴定和表征一种非典型的 Gαs 偏向性βAR 激动剂,该激动剂不能引起气道平滑肌细胞的快速脱敏。
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2026668118.
6
Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.苦味受体 TAS2R5 与 Gi 蛋白复合物的结构和激动剂结合位点,并经过实验验证。
J Phys Chem Lett. 2021 Sep 30;12(38):9293-9300. doi: 10.1021/acs.jpclett.1c02162. Epub 2021 Sep 20.
7
Pseudo-Symmetric Assembly of Protodomains as a Common Denominator in the Evolution of Polytopic Helical Membrane Proteins.原域拟态组装作为多拓扑螺旋膜蛋白进化的共同基础。
J Mol Evol. 2020 May;88(4):319-344. doi: 10.1007/s00239-020-09934-4. Epub 2020 Mar 18.
8
Conformational and Thermodynamic Landscape of GPCR Activation from Theory and Computation.基于理论与计算的G蛋白偶联受体激活的构象和热力学图景
Biophys J. 2016 Jun 21;110(12):2618-2629. doi: 10.1016/j.bpj.2016.04.028.
9
Role of extracellular cysteine residues in the adenosine A2A receptor.细胞外半胱氨酸残基在腺苷A2A受体中的作用。
Purinergic Signal. 2016 Jun;12(2):313-29. doi: 10.1007/s11302-016-9506-7. Epub 2016 Mar 11.
10
Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor.CB1受体新型反向激动剂的计算预测与生化分析
J Chem Inf Model. 2016 Jan 25;56(1):201-12. doi: 10.1021/acs.jcim.5b00581. Epub 2016 Jan 5.